• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绞股蓝皂苷通过调节肠道菌群和短链脂肪酸代谢减轻大鼠非酒精性脂肪性肝病

[Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].

作者信息

Zhong Fang-Wei, Li Geng-Xi, Zeng Li

机构信息

Basic Medical College, Shaoyang University Shaoyang 422000, China.

Hunan Engineering Research Center of Development and Utilization of Traditional Chinese Medicine in Southwest Hunan, Shaoyang University Shaoyang 422000, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2022 May;47(9):2500-2508. doi: 10.19540/j.cnki.cjcmm.20211208.401.

DOI:10.19540/j.cnki.cjcmm.20211208.401
PMID:35531697
Abstract

This study aimed to explore the effects of Gynostemma pentaphyllum saponins(GPs) on non-alcoholic fatty liver disease(NAFLD) induced by high-fat diet in rats and reveal the underlying mechanism. The NAFLD model rats were prepared with high-fat diet. Forty male Sprague Dawley(SD) rats were randomly assigned into the control group, model group, and low-, moderate-, and high-dose GPs(50, 100, and 150 mg·kg~(-1), respectively) groups. After intragastric administration for 8 continuous weeks, we determined the body weight, liver weight, the levels of total cholesterol(TC), triglyceride(TG), low-density lipoprotein cholesterol(LDL-c), high-density lipoprotein cholesterol(HDL-c), alanine aminotransferase(ALT), and aspartate aminotransferase(AST) in serum, and the levels of TC, TG, malondialdehyde(MDA), superoxide dismutase(SOD), catalase(CAT), and interleukin 6(IL-6) in the liver. Furthermore, we observed the pathological changes of liver tissue by oil red O staining and hematoxylin-eosin(HE) staining, sequenced the 16 S rRNA of the intestinal flora in rat feces, and determined the content of short-chain fatty acids in rat feces. The results showed that GPs inhibited the excessive weight gain of high-fat diet-induced NAFLD in rats, reduced the liver weight, lowered the TC, TG, LDL-c, AST, and ALT levels in serum(P<0.05), and rose the HDL-c level in serum(P<0.01). GPs relieved the liver damage caused by high-fat diet, mainly manifested by the lowered levels of TC, TG, MDA, and IL-6 in the liver(P<0.01) and elevated levels of CAT and SOD in the liver. Furthermore, GPs reversed the intestinal flora disorder caused by high-fat diet, restored the diversity of intestinal flora, increased the relative abundance of Bacteroides, and reduced the relative abundance of Firmicutes and the ratio of Firmicutes to Bacteroides. Moreover, GPs promoted the proliferation of beneficial bacteria such as Akkermansia, Bacteroides, and Parabacteroides, and inhibited the growth of harmful bacteria such as Desulfovibrio, Escherichia-Shigella, and Helicobacter. GPs increased the content of short-chain fatty acids(acetic acid, propionic acid, and butyric acid)(P<0.01). These findings indicate that GPs can alleviate the high-fat diet-induced NAFLD in rats via regulating the intestinal flora and short-chain fatty acid metabolism.

摘要

本研究旨在探讨绞股蓝皂苷(GPs)对高脂饮食诱导的大鼠非酒精性脂肪性肝病(NAFLD)的影响,并揭示其潜在机制。采用高脂饮食制备NAFLD模型大鼠。将40只雄性Sprague Dawley(SD)大鼠随机分为对照组、模型组以及低、中、高剂量GPs组(分别为50、100和150 mg·kg⁻¹)。连续灌胃8周后,测定大鼠体重、肝脏重量、血清中总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-c)、高密度脂蛋白胆固醇(HDL-c)、丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)的水平,以及肝脏中TC、TG、丙二醛(MDA)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和白细胞介素6(IL-6)的水平。此外,通过油红O染色和苏木精-伊红(HE)染色观察肝组织的病理变化,对大鼠粪便中的肠道菌群16S rRNA进行测序,并测定大鼠粪便中短链脂肪酸的含量。结果表明,GPs抑制了高脂饮食诱导的NAFLD大鼠体重过度增加,降低了肝脏重量,降低了血清中TC、TG、LDL-c、AST和ALT水平(P<0.05),并提高了血清中HDL-c水平(P<0.01)。GPs减轻了高脂饮食引起的肝脏损伤,主要表现为肝脏中TC、TG、MDA和IL-6水平降低(P<0.01)以及肝脏中CAT和SOD水平升高。此外,GPs逆转了高脂饮食引起的肠道菌群紊乱,恢复了肠道菌群的多样性,增加了拟杆菌属的相对丰度,降低了厚壁菌门的相对丰度以及厚壁菌门与拟杆菌属的比例。而且,GPs促进了诸如阿克曼氏菌、拟杆菌属和副拟杆菌属等有益菌的增殖,并抑制了诸如脱硫弧菌属、埃希氏菌-志贺氏菌属和幽门螺杆菌等有害菌的生长。GPs增加了短链脂肪酸(乙酸、丙酸和丁酸)的含量(P<0.01)。这些研究结果表明,GPs可通过调节肠道菌群和短链脂肪酸代谢减轻高脂饮食诱导的大鼠NAFLD。

相似文献

1
[Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].绞股蓝皂苷通过调节肠道菌群和短链脂肪酸代谢减轻大鼠非酒精性脂肪性肝病
Zhongguo Zhong Yao Za Zhi. 2022 May;47(9):2500-2508. doi: 10.19540/j.cnki.cjcmm.20211208.401.
2
[Components and lipid-lowering effect of total saponins from underground part of Gynostemma pentaphyllum].绞股蓝地下部分总皂苷的成分及降脂作用
Zhongguo Zhong Yao Za Zhi. 2022 Sep;47(18):5022-5031. doi: 10.19540/j.cnki.cjcmm.20220613.701.
3
Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.用绞股蓝缓解大鼠非酒精性脂肪肝病过程中肠道微生物群的结构调节。
BMC Complement Med Ther. 2020 Feb 5;20(1):34. doi: 10.1186/s12906-020-2835-7.
4
[Effect of diosgenin on mTOR/FASN/HIF-1α/VEGFA expression in rats with non-alcoholic fatty liver disease].[薯蓣皂苷元对非酒精性脂肪性肝病大鼠mTOR/FASN/HIF-1α/VEGFA表达的影响]
Zhongguo Zhong Yao Za Zhi. 2023 Apr;48(7):1760-1769. doi: 10.19540/j.cnki.cjcmm.20221123.401.
5
[Effect of Modified Xiaoyao Powder on intestinal barrier and intestinal flora in mice with metabolic associated fatty liver disease based on "gut-liver axis"].基于“肠-肝轴”探讨加味逍遥散对代谢相关脂肪性肝病小鼠肠道屏障及肠道菌群的影响
Zhongguo Zhong Yao Za Zhi. 2024 Aug;49(16):4499-4509. doi: 10.19540/j.cnki.cjcmm.20240506.401.
6
[Difference of lipid-lowering efficacy of "Xinjianqu" before and after fermentation and its mechanism based on LKB1-AMPK pathway and 16S rDNA sequencing technology].["基于LKB1-AMPK通路及16S rDNA测序技术的‘新建曲’发酵前后降脂功效差异及其机制"]
Zhongguo Zhong Yao Za Zhi. 2023 Apr;48(8):2146-2159. doi: 10.19540/j.cnki.cjcmm.20230112.301.
7
Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.绞股蓝总皂苷对高脂高胆固醇饮食和酒精诱导的大鼠脂肪肝的保护作用。
Arch Pharm Res. 2012 Jul;35(7):1241-50. doi: 10.1007/s12272-012-0715-5. Epub 2012 Aug 3.
8
Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.番茄红素对大鼠非酒精性脂肪性肝病的保肝及抗氧化作用
World J Gastroenterol. 2016 Dec 14;22(46):10180-10188. doi: 10.3748/wjg.v22.i46.10180.
9
Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.中药方剂对非酒精性脂肪肝的调控作用。
World J Gastroenterol. 2019 Sep 14;25(34):5105-5119. doi: 10.3748/wjg.v25.i34.5105.
10
Study on the mechanism of Shenling Baizhu powder on the pathogenesis of pregnancy complicated with non-alcoholic fatty liver, based on PI3K/AKT/mTOR signal pathway.基于 PI3K/AKT/mTOR 信号通路探讨参苓白术散治疗妊娠合并非酒精性脂肪肝的作用机制。
Eur J Histochem. 2024 Sep 17;68(3):4093. doi: 10.4081/ejh.2024.4093.

引用本文的文献

1
Structural Characterization of a Novel Pectin Polysaccharide from Mango ( L.) Peel and Its Regulatory Effects on the Gut Microbiota in High-Fat Diet-Induced Obese Mice.芒果(L.)果皮中一种新型果胶多糖的结构表征及其对高脂饮食诱导肥胖小鼠肠道微生物群的调节作用
Foods. 2025 Aug 21;14(16):2910. doi: 10.3390/foods14162910.
2
Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota.植物天然产物对代谢相关脂肪性肝病的影响及其作用机制:以调节肠道菌群为重点的叙述性综述
Front Cell Infect Microbiol. 2024 Feb 20;14:1323261. doi: 10.3389/fcimb.2024.1323261. eCollection 2024.
3
Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders.
肠道菌群:中药改善脂质代谢紊乱的新靶点。
Front Pharmacol. 2023 Mar 1;14:1134430. doi: 10.3389/fphar.2023.1134430. eCollection 2023.